Ingevity Q3 2026: Margin Expansion Tells a Better Story Than Revenue

As seen on the 24/7 Wall St. homepage on November 4, 2026.

NGVT Ingevity
Q3 2026
EPS
$1.63
est $1.59 +2.7%
Revenue
$305M
est $305M +0.1%

Adjusted EBITDA margin expanded 230 basis points to 35.4%, with the Road Markings sale masking organic growth underneath. Management narrowed full-year adjusted EBITDA guidance to $385 million to $395 million and flagged that the Advanced Polymer Technologies sale may slip into early 2027, the next real catalyst for a $2.5 billion company.

Continue ReadingShow less

Ingevity's headline revenue number looks rough at first glance. Sales of $305.1 million fell 8.4% year over year, but that decline is almost entirely explained by the April divestiture of the Road Markings product line. Strip that out and organic sales actually grew 2%, which reframes the quarter considerably for investors trying to gauge the underlying business.

The more meaningful signal is what happened to profitability. Adjusted EBITDA margin from continuing operations expanded 230 basis points to 35.4%, a reflection of pricing discipline and strong execution in Performance Materials even as Pavement Technologies absorbed higher asphalt and logistics costs. GAAP net income rose to $49.3 million, up 13.3% year over year, helped by meaningfully lower interest expense. Adjusted EPS came in at $1.63, beating the $1.59 consensus estimate.

Looking at the segment picture, Performance Materials generated $154.1 million in revenue, supported by resilient North American automotive demand and a consumer preference shift toward hybrid vehicles that has lifted filtration sales. Advanced Polymer Technologies posted $45.0 million in revenue, an 18% increase, driven by better pricing and a mix shift toward higher-value derivative products. Pavement Technologies was the weak spot at $106.0 million, down 24%, weighed down by softer demand and elevated input costs.

Sponsored

Management narrowed full-year 2026 adjusted EBITDA guidance to $385 million to $395 million, maintaining the midpoint of its prior range. The company also reiterated targets of approximately $1.1 billion in net sales and diluted adjusted EPS of $5.25 to $5.45. Free cash flow guidance of $220 million to $230 million excludes the second-quarter $113.2 million litigation settlement payment.

The most closely watched item heading into 2027 is the pending sale of Advanced Polymer Technologies. CEO Dave Li said in the earnings report that the timing of an announced agreement extends into early 2027, pushing back what had been expected as a near-term catalyst for the roughly $2.5 billion company. In the meantime, Ingevity repurchased approximately $39 million of stock in the quarter at a weighted average price of $71.45 per share, with about $172 million of buyback capacity remaining under the current authorization.

Mentioned: NGVT